Altre lingue Eledon Pharmaceuticals, Inc.

Azioni

ELDN

US28617K1016

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
2,39 ^USD	+0,84%		+10,65%	+32,78%

28/03	Eledon Pharmaceuticals, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
25/03	Eledon Pharmaceuticals dice che il 12° partecipante è stato arruolato nello studio su tegoprubart; le azioni salgono dopo le ore.	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results	28/03
Eledon Pharmaceuticals Says 12th Participant Enrolled in Tegoprubart Trial; Shares Rise After Hours	25/03
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	25/03
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	25/03
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	21/03
Sector Update: Health Care	21/03
Eledon Pharmaceuticals Says Tegoprubart Used in Kidney Transplant From Pig to Human	21/03
USA-Un homme greffé avec le rein d'un porc, une première mondiale	21/03
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	21/03
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	21/03
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	14/02
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	14/02
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook	04/01
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05/12
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05/12
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference	29/11
Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results	09/11
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference	08/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Eledon Pharmaceuticals, Inc.

Azioni

ELDN

US28617K1016

Altre lingue

Filtri